Event Date:
August 13, 2019

Saif Lalani

44:50 Minutes

Prostaid Calgary Director Saif Lalani looks at today’s changing landscape for prostate cancer treatment with a deeper look at the following treatments: Darolutamide, Xofigo/Radium 223, and Prostate Specific Membrane Antigen (PSMA), their qualities and their availability today in Canada and beyond.

Leave a Reply

Your email address will not be published. Required fields are marked *